Sepsis remains a top healthcare priority. 48.9 million cases of sepsis occur each year and the average cost per hospital stay for sepsis is double the average cost per stay across all other conditions. Timely and effective antibiotic treatment for sepsis patients is critical. For patients with serious infections (i.e. blood stream infections), reducing time to effective therapy has been associated with decreased mortality.
There is a delicate balance between timely, broad-spectrum antibiotics and preventing the acceleration of antimicrobial resistance highlighting the need for more rapid phenotypic susceptibility testing. In this webinar, Dr. Linoj Samuel will highlight currently available technology enabling fast phenotypic antimicrobial susceptibility testing (“Fast AST”), potential applications, limitations, and considerations towards implementing novel technology to deliver improved patient outcomes.
This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, point-of-care coordinators, pathologists, and other laboratory professionals overseeing/conducting within this topic.
At the end of this session, participants will be able to:
– Explain the applications of fast antimicrobial susceptibility testing (AST) in blood culture workflow.
– Review the current fast AST landscape, available platforms, and technology.
– Discuss implementation strategies of new AST technologies, including potential barriers, considerations, and risks.
Date: Dec 04, 2024
Times: 1:00-2:00 PM ET
Location: Live Webinar
CE Credits: 1.0 ACCENT
Duration: 1 hour
Recorded: This will be on demand for a year after the event.
Price: Free
Registration: https://www.myadlm.org/education/all-webinars/webinars/2024/december/the-need-for-speed-in-phenotypic-antimicrobial-susceptibility-testing
